Ignite Creation Date:
2024-05-05 @ 12:04 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00232596
Status:
COMPLETED
Last Update Posted:
2016-12-08
First Post:
2005-09-30
Brief Title:
Retigabine Adjunctive Therapy Efficacy and Safety Study for Partial Onset Refractory Seizures in Epilepsy
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-09
Start Date Type:
None
Primary Completion Date:
2008-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-01
Completion Date Type:
ACTUAL
First Submit Date:
2005-09-30
First Submit QC Date:
September 30 2005
Study First Post Date:
2005-10-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2011-10-25
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-10-26
Last Update Post Date:
2016-12-08
Last Update Post Date Type:
ESTIMATED